GFM
AURA icon

GF Fund Management’s Aura Biosciences AURA Stock Holding History

GF Fund Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Buy
2,043
+627
+44% +$4.49K ﹤0.01% 509
2026
Q1 		$9.47K Buy
1,416
+169
+14% +$970 ﹤0.01% 559
2025
Q4 		$6.8K Sell
1,247
-89
-7% -$529 ﹤0.01% 605
2025
Q3 		$8.26K Buy
1,336
+57
+4% +$373 ﹤0.01% 571
2025
Q2 		$8.01K Hold
1,279
– – ﹤0.01% 591
2025
Q1 		$7.5K Buy
1,279
+230
+22% +$1.74K ﹤0.01% 593
2024
Q4 		$8.62K Buy
+1,049
New +$9.87K ﹤0.01% 567

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

GF Fund Management's AURA Position: Q2 2026 in Review

GF Fund Management increased its Aura Biosciences (AURA) stake by 44% in Q2 2026, buying an estimated $4.49K and bringing the position to 2,043 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

GF Fund Management first reported a position in AURA in Q4 2024 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • GF Fund Management held 2,043 shares of Aura Biosciences worth $14.5K as of Q2 2026.
  • GF Fund Management bought 627 Aura Biosciences shares in Q2 2026, an estimated $4.49K.
  • Aura Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #509 holding.
  • GF Fund Management first reported a position in Aura Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.